TAPENTADOL HYDROCHLORIDE | A214378 | EPIC PHARMA LLC
No patent or exclusivity listings for this strength.
EPIC PHARMA LLC became the applicant for tapentadol hydrochloride NDA 214378 supplement 002, replacing HUMANWELL PHARMACEUTICAL US INC.
Old: HUMANWELL PHARMACEUTICAL US INC
New: EPIC PHARMA LLC
EPIC PHARMA LLC became the applicant for tapentadol hydrochloride NDA 214378 following a transfer from HUMANWELL.
Old: HUMANWELL
New: EPIC PHARMA LLC
Applicant for tapentadol hydrochloride (NDA 214378) changed from Humanwell Pharmaceutical US Inc to Epic Pharma LLC.
Old: HUMANWELL PHARMACEUTICAL US INC
New: EPIC PHARMA LLC
Epic Pharma LLC replaced Humanwell Pharmaceutical US Inc as the applicant for tapentadol hydrochloride NDA 214378.
Old: HUMANWELL PHARMACEUTICAL US INC
New: EPIC PHARMA LLC
Epic Pharma LLC replaced Humanwell as the NDA 214378 applicant for Tapentadol Hydrochloride oral solution, reflecting a change in product ownership or sponsorship.
Old: HUMANWELL
New: EPIC PHARMA LLC
EPIC Pharma LLC became the applicant for NDA 214378 (Tapentadol Hydrochloride) following a change from Humanwell.
Old: HUMANWELL
New: EPIC PHARMA LLC